October 1, 2012—March 27, 2013
The NIH will operate under a Continuing Resolution (H.J. Resolution 117), signed as Public Law 112-175. Government operations will continue at the FY2012 level plus 0.6 percent.
Until the FY2013 appropriations are enacted, NEI will issue non-competing research grant awards at a level generally up to 90% of the previously committed level on the most recent Notice of Award. Upward adjustments will be considered after the appropriations are enacted, but we expect institutions to monitor their expenditures carefully during this period.
All legislative mandates that were in effect in FY2012 remain in effect under the CR. http://grants.nih.gov/grants/guide/notice-files/NOT-OD-13-002.html
March 1, 2013 - March 27, 2013
The NIH is operating under a sequestration order for FY 2013 in accordance with section 251A of the Balanced Budget and Emergency Deficit Control Act, as amended. See http://grants.nih.gov/grants/financial/sequestration_letter_to_grantees.pdf PDF*
March 27, 2013 - September 30, 2013
The NEI is operating for the remainder of the Fiscal Year under the Consolidated and Further Continuing Appropriations Act, 2013 (P.L. 113-6) and the sequestration provisions of the Balanced Budget and Emergency Deficit Control Act, as amended, 2 U.S.C. § 901a.
Non-competing Awards: The Research Project Grants (RPG) in this category includes the R00, R01, R21, R34, and DP2 grant mechanisms. NEI RPGs will be issued at 95% of the previously committed level on the most recent Notice of Award (NOA). All continuing RPGs which had been reduced to the 90% level earlier in the year will be reissued with an upward adjustment to the 95% level. NOAs for all non-RPG continuing grant mechanisms will be issued at the recommended level. No annual inflation increments will be provided in future years for any grants.
Competing Awards: NEI expects to issue a total of 267 competitive RPG awards (compared with 296 in FY2012, a 10% reduction), with average total costs of $404,300 (no change from FY2012). The award rate (number of applications funded divided by the number of applications reviewed) for RPGs is anticipated to be 26% (compared with 30% for FY2012). NEI will continue to support new investigators on R01-equivalent grant awards at a success rate equivalent to that of established investigators submitting new R01-equivalent applications. Approximately 60% of these new investigators will be Early Stage Investigators (within seven years of the terminal professional degree). NEI will also continue to manage the portfolio average length of grants to four years, by funding approximately equal numbers of three, four, and five year awards. This is done in to insure, as much as possible, that equivalent numbers of continuing applications will compete for funds in future years.
The NEI anticipates that the numbers of Small Business, Center Core Grant, Career Development, training awards, translational, and cooperative clinical research awards will remain relatively constant compared with the FY2012 levels.
All legislative mandates that were in effect in FY2012 remain in effect under the CR. http://grants.nih.gov/grants/guide/notice-files/NOT-OD-13-002.html.
Last Updated: June 2013